Literature DB >> 8994069

Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): immunohistochemical studies.

A C Granholm1, N Srivastava, J L Mott, S Henry, M Henry, H Westphal, J G Pichel, L Shen, B J Hoffer.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a member of the TGF-beta superfamily of growth factors with neurotrophic activity on midbrain dopaminergic neurons and on developing and mature motoneurons of the brainstem and spinal cord. To investigate the extent of GDNF dependency of central and peripheral nervous structures during development, we have performed an immunohistochemical analysis of sections from the whole head including brain, peripheral ganglia, developing teeth and tongue, as well as intestines, in mutant mice lacking a part of the third exon that encodes the GDNF protein. As described previously, these null-mutated mice lack most of the enteric nerve plexus and are subject to agenesis or severe dysgenesis of the kidneys. In the present communication, we examined the development of vibrissae and incisor and molar teeth, as well as the innervation of these structures, and found no differences between null-mutated and control mice. A decrease in the immunohistochemical labeling intensity with tyrosine hydroxylase was observed in the superior cervical ganglion (SCG), as well as in the pontine nucleus locus coeruleus, and the sympathetic innervation of blood vessels and glands in the head was significantly decreased. None of the brain nuclei studied exhibited any significant decreases in the total number of neurons, but the packing density of neurons in the nucleus locus coeruleus was decreased. These data indicate that GDNF might be one neurotrophic factor that contributes to the development of central and peripheral noradrenergic neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8994069      PMCID: PMC6573173     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  GDNF signalling through the Ret receptor tyrosine kinase.

Authors:  P Durbec; C V Marcos-Gutierrez; C Kilkenny; M Grigoriou; K Wartiowaara; P Suvanto; D Smith; B Ponder; F Costantini; M Saarma
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

2.  Renal and neuronal abnormalities in mice lacking GDNF.

Authors:  M W Moore; R D Klein; I Fariñas; H Sauer; M Armanini; H Phillips; L F Reichardt; A M Ryan; K Carver-Moore; A Rosenthal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

3.  GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo.

Authors:  E Arenas; M Trupp; P Akerud; C F Ibáñez
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

4.  NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain?

Authors:  H Gnahn; F Hefti; R Heumann; M E Schwab; H Thoenen
Journal:  Brain Res       Date:  1983-07       Impact factor: 3.252

5.  Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.

Authors:  L R Williams; G Inouye; V Cummins; M A Pelleymounter
Journal:  J Pharmacol Exp Ther       Date:  1996-05       Impact factor: 4.030

6.  Severe sensory and sympathetic deficits in mice lacking neurotrophin-3.

Authors:  I Fariñas; K R Jones; C Backus; X Y Wang; L F Reichardt
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

7.  Glial cell line-derived neurotrophic factor enhances survival and growth of prenatal and postnatal spinal cord transplants.

Authors:  K Trok; B Hoffer; L Olson
Journal:  Neuroscience       Date:  1996-03       Impact factor: 3.590

8.  In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons.

Authors:  Q Yan; C Matheson; O T Lopez
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

9.  Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons.

Authors:  C Crowley; S D Spencer; M C Nishimura; K S Chen; S Pitts-Meek; M P Armanini; L H Ling; S B McMahon; D L Shelton; A D Levinson
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo.

Authors:  E Arenas; H Persson
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

View more
  19 in total

Review 1.  Regulation of GDNF expression in Sertoli cells.

Authors:  Parag A Parekh; Thomas X Garcia; Marie-Claude Hofmann
Journal:  Reproduction       Date:  2019-03       Impact factor: 3.906

2.  Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits.

Authors:  Yuxin Liu; Liya Qin; Belinda Wilson; Xuefei Wu; Li Qian; Ann-Charlotte Granholm; Fulton T Crews; Jau-Shyong Hong
Journal:  Neurotoxicology       Date:  2008-03-13       Impact factor: 4.294

3.  Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.

Authors:  A C Granholm; M Reyland; D Albeck; L Sanders; G Gerhardt; G Hoernig; L Shen; H Westphal; B Hoffer
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

4.  Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.

Authors:  J T Erickson; T A Brosenitsch; D M Katz
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

Review 5.  From proliferation to target innervation: signaling molecules that direct sympathetic nervous system development.

Authors:  W H Chan; C R Anderson; David G Gonsalvez
Journal:  Cell Tissue Res       Date:  2017-10-02       Impact factor: 5.249

6.  Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth.

Authors:  Yongwoo Jang; Jooyoung Jung; Hyungsup Kim; Jungeun Oh; Ji Hyun Jeon; Saewoon Jung; Kyung-Tai Kim; Hawon Cho; Dong-Jin Yang; Sung Min Kim; In-Beom Kim; Mi-Ryoung Song; Uhtaek Oh
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

7.  Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

Authors:  Sara af Bjerkén; Heather A Boger; Matthew Nelson; Barry J Hoffer; Ann-Charlotte Granholm; Ingrid Strömberg
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

Review 8.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

9.  Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene.

Authors:  Heather A Boger; Lawrence D Middaugh; Vandana Zaman; Barry Hoffer; Ann-Charlotte Granholm
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

Review 10.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.